» Articles » PMID: 6339023

A Guide to the Pharmacology of Placebos

Overview
Journal Can Med Assoc J
Specialty General Medicine
Date 1983 Apr 15
PMID 6339023
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The placebo effect is capable of relieving pain in a substantial proportion of patients; affective disorders also respond to the administration of inert medication. Changes in objective measures, such as blood pressure and blood glucose levels, demonstrate the action of placebos. The underlying mechanisms are not yet known, but because the nature and strength of the placebo response are governed by the patient's perceptions, both positive and negative results may be obtained. The complexity of human perception has made it extremely difficult to characterize the people who react. In clinical situations the placebo may be underused as a therapeutic agent, while in clinical trials the effect may be inadequately evaluated; the power and nature of the placebo effect truly warrant greater recognition.

Citing Articles

Comparison of Placebo Effect between Asian and Caucasian Type 2 Diabetic Patients: A Meta-Analysis.

Guo W, Nie L, Wang X, Xu M, Yang W, Gao X Chin Med J (Engl). 2018; 131(13):1605-1612.

PMID: 29941715 PMC: 6032690. DOI: 10.4103/0366-6999.235107.


Effect of metformin glycinate on glycated hemoglobin A1C concentration and insulin sensitivity in drug-naive adult patients with type 2 diabetes mellitus.

Gonzalez-Ortiz M, Martinez-Abundis E, Robles-Cervantes J, Ramos-Zavala M, Barrera-Duran C, Gonzalez-Canudas J Diabetes Technol Ther. 2012; 14(12):1140-4.

PMID: 22974412 PMC: 3521136. DOI: 10.1089/dia.2012.0097.


[Dose-response relation: relevance for clinical practice].

Klinkhardt U, Harder S Med Klin (Munich). 1999; 93(12):744-9.

PMID: 10024846 DOI: 10.1007/BF03044815.


Adverse Drug Reaction Reporting Program of the Ontario Medical Association: the first 3 years.

Gowdey C, Brennan M Can Med Assoc J. 1985; 132(1):19-23.

PMID: 3871167 PMC: 1346498.


Dose-finding studies in clinical drug development.

Schmidt R Eur J Clin Pharmacol. 1988; 34(1):15-9.

PMID: 3360047 DOI: 10.1007/BF01061410.

References
1.
Gowdey C, Hamilton J, PHILP R . A controlled clinical trial using placebos in normal subjects: a teaching exercise. Can Med Assoc J. 1967; 96(19):1317-22. PMC: 1922905. View

2.
POGGE R, COATS E . The placebo as a source of side effects in normal people: influence of gradually increasing doses. Nebr State Med J. 1962; 47:337-9. View

3.
Budoff P . Zomepirac sodium in the treatment of primary dysmenorrhea syndrome. N Engl J Med. 1982; 307(12):714-9. DOI: 10.1056/NEJM198209163071203. View

4.
Lasagna L, VON FELSINGER J, BEECHER H . Drug-induced mood changes in man. I. Observations on healthy subjects, chronically ill patients, and postaddicts. J Am Med Assoc. 1955; 157(12):1006-20. DOI: 10.1001/jama.1955.02950290026009. View

5.
Freund J, Krupp G, Goodenough D, Preston L . The doctor-patient relationship and drug effect. Clin Pharmacol Ther. 1972; 13(2):172-80. DOI: 10.1002/cpt1972132172. View